Unknown

Dataset Information

0

Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus.


ABSTRACT: We report the synthesis and antimicrobial studies of a new series of naphthyl-substituted pyrazole-derived hydrazones. Many of these novel compounds are potent growth inhibitors of several strains of drug-resistant bacteria. These potent compounds have inclined growth inhibitory properties for planktonic Staphylococcus aureus and Acinetobacter baumannii, and its drug-resistant variants with minimum inhibitory concentration (MIC) as low as 0.78 and 1.56?µg?ml-1, respectively. These compounds also show potent activity against S. aureus and A. baumannii biofilm formation and eradication properties. Time Kill Assay shows that these compounds are bactericidal for S. aureus and bacteriostatic for A. baumannii. The probable mode of action is the disruption of the bacterial cell membrane. Furthermore, potent compounds are nontoxic to human cell lines at several fold higher concentrations than the MICs.

SUBMITTER: Alnufaie R 

PROVIDER: S-EPMC7655718 | biostudies-literature | 2020 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

Design and synthesis of 4-[4-formyl-3-(2-naphthyl)pyrazol-1-yl]benzoic acid derivatives as potent growth inhibitors of drug-resistant Staphylococcus aureus.

Alnufaie Rawan R   Alsup Nickolas N   Kc Hansa Raj HR   Newman Matthew M   Whitt Jedidiah J   Chambers Steven Andrew SA   Gilmore David D   Alam Mohammad A MA  

The Journal of antibiotics 20200629 12


We report the synthesis and antimicrobial studies of a new series of naphthyl-substituted pyrazole-derived hydrazones. Many of these novel compounds are potent growth inhibitors of several strains of drug-resistant bacteria. These potent compounds have inclined growth inhibitory properties for planktonic Staphylococcus aureus and Acinetobacter baumannii, and its drug-resistant variants with minimum inhibitory concentration (MIC) as low as 0.78 and 1.56 µg ml<sup>-1</sup>, respectively. These com  ...[more]

Similar Datasets

| S-EPMC6600224 | biostudies-literature
| S-EPMC6733178 | biostudies-literature
| S-EPMC5486227 | biostudies-literature
| S-EPMC3569238 | biostudies-literature
| S-EPMC3766874 | biostudies-other
| S-EPMC5045767 | biostudies-literature
| S-EPMC3829614 | biostudies-literature
| S-EPMC4499817 | biostudies-literature
| S-EPMC4353699 | biostudies-literature
| S-EPMC3417054 | biostudies-literature